Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia

• Silvia Martinelli,
• Rossana Maffei,
• Stefania Fiorcari,
• Chiara Quadrelli,
• Patrizia Zucchini,
• Stefania Benatti,
• Leonardo Potenza,
• Mario Luppi,
• Roberto Marasca

Affiliations

Silvia Martinelli

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Rossana Maffei

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Stefania Fiorcari

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Chiara Quadrelli

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Patrizia Zucchini

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Stefania Benatti

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Leonardo Potenza

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Mario Luppi

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy

Roberto Marasca

Hematology Division, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy